Last update 08 May 2025

30S subunit x ERβ

Basic Info

Related Targets
30S subunitERβ

Related

1
Drugs associated with 30S subunit x ERβ
AUS-131/Doxycycline
Target
30S subunit x ERβ
Mechanism
30S subunit inhibitors [+1]
Active Org.-
Originator Org.
Nexgen Dermatologics, Inc.
Active Indication-
Inactive Indication
Acne Vulgaris
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with 30S subunit x ERβ
Login to view more data
100 Translational Medicine associated with 30S subunit x ERβ
Login to view more data
0 Patents (Medical) associated with 30S subunit x ERβ
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free